PRO: Do We Still Need Whole-Brain Irradiation for Brain Metastases?
Cancers · 15.06.2023 · 15 (12) · 3193
DOI: 10.3390/cancers15123193 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 15.06.2023. Verfasst von Ilinca Popp und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
(1)
Background
In recent decades, the use of whole-brain radiation therapy (WBRT) in the treatment of brain metastases has significantly decreased, with clinicians fearing adverse neurocognitive events and data showing limited efficacy regarding local tumor control and overall survival. The present study thus aimed to reassess the role that WBRT holds in the treatment of brain metastases. (2)
Methods
This review summarizes the available evidence from 1990 until today supporting the use of WBRT, as well as new developments in WBRT and their clinical implications. (3)
Results
While one to four brain metastases should be exclusively treated with radiosurgery, WBRT does remain an option for patients with multiple metastases. In particular, hippocampus-avoidance WBRT, WBRT with dose escalation to the metastases, and their combination have shown promising results and offer valid alternatives to local stereotactic radiotherapy. Ongoing and published prospective trials on the efficacy and toxicity of these new methods are presented. (4)
Conclusions
Unlike conventional WBRT, which has limited indications, modern WBRT techniques continue to have a significant role to play in the treatment of multiple brain metastases. In which situations radiosurgery or WBRT should be the first option should be investigated in further studies. Until then, the therapeutic decision must be made individually depending on the oncological context.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
- German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Partner Site Freiburg, 69120 Heidelberg, Germany.
- Department of Oncology and Palliative Medicine, Nordland Hospital, 8092 Bodø, Norway.
- Department of Clinical Medicine, Faculty of Health Sciences, UiT-The Arctic University of Norway, 9037 Tromsø, Norway.
Zitieren
APA
Popp, I., Hartong, N. E., Nieder, C., & Grosu, A. L. (2023). PRO: Do We Still Need Whole-Brain Irradiation for Brain Metastases?. Cancers, 15(12), 3193. https://doi.org/10.3390/cancers15123193
Vancouver
Popp I, Hartong NE, Nieder C, Grosu AL. PRO: Do We Still Need Whole-Brain Irradiation for Brain Metastases?. Cancers. 2023;15(12):3193. doi:10.3390/cancers15123193
BibTeX
@article{Popp2023,
author = {Popp, Ilinca and Hartong, Nanna E and Nieder, Carsten and Grosu, Anca-L},
title = {PRO: Do We Still Need Whole-Brain Irradiation for Brain Metastases?},
journal = {Cancers},
year = {2023},
volume = {15},
number = {12},
pages = {3193},
doi = {10.3390/cancers15123193}
}
EUVIMED